Howard Marks’s Future Health ESG Corp. Common stock FHLT Stock Holding History

Howard Marks’s Portfolio FHLT Stock Details FHLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-250,000	Closed	-$2.5M	–	369
2022 Q3	$2.5M	Hold	250,000	–	–	0.03%	254
2022 Q2	$2.47M	Hold	250,000	–	–	0.03%	240
2022 Q1	$2.46M	Hold	250,000	–	–	0.03%	233
2021 Q4	$2.44M	Buy	+250,000	New	+$2.45M	0.03%	220

Other funds holding FHLT

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Howard Marks's FHLT Position: Q4 2022 in Review

Howard Marks sold out of Future Health ESG Corp. Common stock (FHLT) in Q4 2022, closing a stake of 250,000 shares — an estimated $2.5M sold.

Howard Marks first reported a position in FHLT in Q4 2021 and held it in 4 quarters. The position peaked at $2.5M in Q3 2022. 10 funds tracked by Wall St. Rank hold FHLT as of Q4 2022.

Howard Marks reported no remaining Future Health ESG Corp. Common stock position as of Q4 2022 after selling out during the quarter.
Howard Marks sold 250,000 Future Health ESG Corp. Common stock shares in Q4 2022, an estimated $2.5M.
Howard Marks first reported a position in Future Health ESG Corp. Common stock in Q4 2021 and held it in 4 quarters.
Howard Marks's Future Health ESG Corp. Common stock position peaked at $2.5M in Q3 2022.
10 funds tracked by Wall St. Rank held Future Health ESG Corp. Common stock as of Q4 2022.

Based on Oaktree Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.